Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data

Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data

Christine L Baker,1 Kelly H Zou,1 Jun Su21Pfizer Inc., New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USABackground: Treatment of stable chronic obstructive pulmonary disease (COPD) with long-acting bronchodilator (LABD) medications is recommended by the 2014 Global...

Full description

Bibliographic Details
Main Authors:	Baker CL, Zou KH, Su J
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-05-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/long-acting-bronchodilator-use-after-hospitalization-for-copd-an-obser-a16627

Similar Items

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
by: Kang J, et al.
Published: (2017-12-01)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
by: Bishwakarma R, et al.
Published: (2017-01-01)

Bronchodilators use in patients with COPD
by: Dong YH, et al.
Published: (2015-09-01)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
by: Donohue JF, et al.
Published: (2019-12-01)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
by: Matera MG, et al.
Published: (2015-12-01)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?
by: Marc Miravitlles, M.D., et al.
Published: (2018-07-01)

Salmeterol: a long acting bronchodilator.
by: Bhadoria D, et al.
Published: (1995-01-01)

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
by: Vogelmeier CF, et al.
Published: (2021-05-01)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
by: Kozma Chris M, et al.
Published: (2011-12-01)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-01-01)

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
by: Wurst KE, et al.
Published: (2014-09-01)

Risk assessment of readmissions following an initial COPD-related hospitalization
by: Baker CL, et al.
Published: (2013-11-01)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-04-01)

Comparative studies of dual bronchodilation in COPD
by: Mario Cazzola, et al.
Published: (2021-02-01)

Optimizing bronchodilation in the prevention of COPD exacerbations
by: Marc Miravitlles, et al.
Published: (2017-06-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study
by: Voduc N, et al.
Published: (2012-03-01)

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
by: Singh D, et al.
Published: (2019-12-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

Impact of bronchodilator therapy on exercise tolerance in COPD
by: B Aguilaniu
Published: (2010-03-01)

Predictors of Single Bronchodilation Treatment Response for COPD: An Observational Study with the Trace Database Cohort
by: Laura Carrasco Hernández, et al.
Published: (2021-04-01)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
by: Melissa H. Roberts, et al.
Published: (2019-12-01)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
by: Asche CV, et al.
Published: (2012-03-01)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01)

Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01)

Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
by: Yoshiaki Minakata, et al.
Published: (2020-10-01)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
by: Mario Cazzola, et al.
Published: (2019-11-01)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
by: James F Donohue, et al.
Published: (2011-01-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
by: Jaco Voorham, et al.
Published: (2019-08-01)

Effect of prednisolone on lung function and bronchodilator responses in stable COPD
by: Chhabra S, et al.
Published: (2006-01-01)

Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial
by: Ramírez-Venegas A, et al.
Published: (2019-08-01)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
by: Pascoe S, et al.
Published: (2016-08-01)

Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials
by: Li CX, et al.
Published: (2019-04-01)

Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
by: Rod Jackson, et al.
Published: (2021-08-01)

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD
by: Kardos P, et al.
Published: (2016-11-01)

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice
by: Р. A. Balunov, et al.
Published: (2019-01-01)

Fixed-dose combinations of bronchodilators in the treatment of patients with COPD: problem of choice
by: A. I. Sinopalnikov
Published: (2018-10-01)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
by: Gong S, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_2rouu1o7u2pa1regmd4tdliiaj